CEREVIA
LIVE

Serial Number

99870481

Owner

NoseOption AB

Attorney

Maurine Knutsson

Filing Date

Jun 8, 2026

Add to watchlist:

No watchlists yet
View on USPTO

CEREVIA Trademark

Serial Number: 99870481

CEREVIA is a trademark filed by NoseOption AB on June 8, 2026. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently pending registration.

Owner Contact Info

NoseOption AB (2 trademarks)

Surbrunnsgatan 42
Stockholm SE-113 48 , SE

Entity Type: 99

Trademark Details

Filing Date

June 8, 2026

Registration Date

Not Registered

Goods & Services

Pharmaceutical preparations for the treatment and prevention of cognitive disorders, sleep disorders, psychiatric diseases and disorders, viral infections and diseases, bacterial infections and diseases, allergies, opioid use disorder, and neurological diseases and disorders in the form of medicated nasal plugs and inserts; Biological preparations for the prevention and treatment of cognitive disorders, sleep disorders, psychiatric diseases and disorders, viral infections and diseases, bacterial infections and diseases, allergies, opioid use disorder, and neurological diseases and disorders in the form of medicated nasal plugs and inserts; Biologics in the nature of pharmaceutical preparations for the treatment of cognitive disorders, sleep disorders, psychiatric diseases and disorders, viral infections and diseases, bacterial infections and diseases, allergies, opioid use disorder, and neurological diseases and disorders in the form of medicated nasal plugs and inserts; Peptides for the treatment of cognitive disorders, sleep disorders, psychiatric diseases and disorders, viral infections and diseases, bacterial infections and diseases, allergies, opioid use disorder, and neurological diseases and disorders in the form of medicated nasal plugs and inserts; Drug delivery agents in the form of nasal plugs and inserts for the controlled release of drugs, nasal drug delivery devices, drug-eluting nasal plugs and inserts, medicated nasal inserts and plugs, controlled-release nasal delivery apparatus, nasal inserts and plugs pre-filled with pharmaceutical preparations, and nasal plugs and inserts for medical purposes that facilitate the delivery of pharmaceutical preparations that facilitate the delivery of pharmaceutical preparations; Pharmaceutical preparations for reversing the effects of opioid overdoses; Pharmaceutical preparations in the form of medicated nasal insert and plug opioid receptor antagonists for the treatment of acute opioid overdoses; Central nervous system stimulants

Drug delivery devices sold empty, namely, nasal plugs and inserts for the controlled release of drugs, nasal drug delivery devices, drug-eluting nasal plugs and inserts, nasal inserts and plugs that can be medicated, and controlled-release nasal delivery apparatus; Drug delivery devices sold empty, namely, nasal plugs and inserts for medical purposes that facilitate the delivery of pharmaceutical preparations, nasal plugs and inserts for medical purposes that facilitate the delivery of biological preparations, nasal plugs and inserts for medical purposes that facilitate the delivery of biologics, and nasal plugs and inserts for medical purposes that facilitate the delivery of peptides; Drug delivery devices sold empty, namely, nasal inserts and plugs for filing with pharmaceutical preparations, nasal inserts and plugs for filing with biological preparations, nasal inserts and plugs for filing with biologics, and nasal inserts and plugs for filing with peptides

Filing History

APPLICATION FILING RECEIPT MAILED
Jun 8, 2026 MAFR
NEW APPLICATION ENTERED
Jun 8, 2026 NWAP